Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Porcine PCV2 Vaccine
- Development stage
- Preclinical
- Lead developer
- SET Technology
- Modality
- mRNA Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Intramuscular
01
Overview
Porcine PCV2 Vaccine is a nucleic acid-based (DNA/RNA) vaccine candidate being developed by SET Technology for the prevention of Porcine Circovirus Type 2 (PCV2) infection in swine. PCV2 is a significant pathogen in the global pork industry, associated with Porcine Circovirus Disease (PCVD), which includes symptoms such as wasting, respiratory distress, and skin lesions. The vaccine aims to leverage SET Technology's platform to provide effective immunization against the virus. As of early 2025, the program is in the preclinical optimization phase.
- Other names
- Porcine Circovirus Type 2 VaccinePCV2 VaccinePCV-2 VaccinePCV 2 Vaccine
02
Targets
CR2 (Complement receptor type 2)Porcine circovirus type 2a capsid proteinPorcine circovirus type 2b capsid proteinSLA-1*04:01 (Swine leukocyte antigen-1*04:01)PCV2 Cap (Porcine circovirus type 2 capsid protein)TLR5TLR9 (Toll-like receptor 9)PCV2 (Porcine circovirus 2)
Beyond the preview
Go deeper on Porcine PCV2 Vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Porcine PCV2 Vaccine.